BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Teza Capital Management LLC 36,904$261,2800.02%
Legato Capital Management LLC 23,225$164,4330.02%
MOODY NATIONAL BANK TRUST DIVISION 52,046$368,4860.02%
FIRST MANHATTAN CO. LLC. 874,840$6,193,8670.02%
Golden State Equity Partners 10,925$77,3490.02%
E Fund Management Co., Ltd. 41,497$2940.02%
Alkeon Capital Management 1,672,313$11,839,9760.02%
GRIMES & COMPANY, INC. 73,575$520,9110.02%
Connor, Clark & Lunn Investment Management Ltd. 542,776$3,842,8540.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 470,137$3,328,5700.02%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 225,323$1,595,2870.02%
Visionary Wealth Advisors 33,540$237,4630.02%
Aquatic Capital Management LLC 64,600$4570.02%
STIFEL FINANCIAL CORP 1,844,019$13,055,6550.02%
MILLENNIUM MANAGEMENT LLC 4,983,207$35,281,1060.02%
Engineers Gate Manager LP 66,900$473,6520.02%
Dynamic Technology Lab Private Ltd 22,609$1600.02%
HRT FINANCIAL LP 212,698$1,5050.02%
Fisher Asset Management, LLC 3,185,199$22,551,2080.01%
Stonegate Investment Group, LLC 48,988$346,8350.01%
External links

This page lists BIOCRYST PHARMACEUTICALS INC's shareholders in Q3 2023. To view BIOCRYST PHARMACEUTICALS INC's shareholder history, click here.